On November 17, 2015, Harrison M. Bains notified BG Medicine, Inc. that he was resigning from the company's board of directors, effective as of that date. Mr. Bains did not communicate to the company any disputes regarding the company's coperations, policies or practices in connection with his resignation, nor is the company aware of any. On November 18, 2015, the board appointed James F. O'Connor, CPA, to join the board to serve as a Class II director until the 2016 Annual Meeting of Stockholders and until his successor has been duly elected and qualified, or until his earlier resignation, retirement, removal or death.

The board also appointed Mr. O'Connor to the Audit Committee and to the role of Audit Committee Chairman. The board further determined that Mr. O'Connor is an audit committee financial expert as defined by Item 401(h) of Regulation S-K. There are no arrangements or understandings between the company and any other person pursuant to which Mr. O'Connor was selected as a director, nor are there any transactions between Mr. O'Connor and the Company in which he has a direct or indirect material interest that the company is required to report pursuant to the rules and regulations of the Securities and Exchange Commission. Since 1998, Mr. O'Connor has been the principal Managing Director of The Chartwell Company.

Mr. O'Connor is a certified public accountant.